Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-053032
Filing Date
2015-06-12
Accepted
2015-06-12 21:12:24
Documents
2
Period of Report
2015-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5361
2 POA DOCUMENT poa.txt EX-24.3_589764 3425
  Complete submission text file 0001209191-15-053032.txt   10129
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 701 GATEWAY BOULEVARD, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address
Ha Pamela (Reporting) CIK: 0001644691 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 15929872